Cardiovascular surrogate markers and cardiometabolic therapeutics: a viewpoint learned from clinical trials on dipeptidyl peptidase-4 inhibitors | Cardiovascular Diabetology | Full Text
The use of surrogate end points in cardiovascular disease and diabetes - The British Journal of Cardiology
attenuation parameter - List of Frontiers' open access articles
Example 1: Continuous Surrogate Marker • OptimalSurrogate
Cardiovascular surrogate markers and cardiometabolic therapeutics: a viewpoint learned from clinical trials on dipeptidyl peptidase-4 inhibitors | Cardiovascular Diabetology | Full Text
Diagnostics | Free Full-Text | Arterial Stiffness as a Surrogate Marker of Cardiovascular Disease and Atherosclerosis in Patients with Arthritides and Connective Tissue Diseases: A Literature Review
Proteomics of Hepatocellular Carcinoma: Serum Vimentin As a Surrogate Marker for Small Tumors (≤2 cm) | Journal of Proteome Research
Surrogate markers of infection: interrogation of the immune system | Biomarkers in Medicine
Table I from Surrogate markers in HIV disease. | Semantic Scholar
Surrogate Markers of Vision* | Download Table
Reticulocytosis as a Surrogate Marker of Recent Pf Malaria Infection: Association with Clinical, Parasitological and Haematological outcomes: Okoth, Patrick: 9783845437156: Amazon.com: Books
Assessment of antibiotic-resistant organism transmission among rooms of hospitalized patients, healthcare personnel, and the hospital environment utilizing surrogate markers and selective bacterial cultures | Infection Control & Hospital Epidemiology ...
Surrogate Endpoint | Definitive Healthcare
What Do We Know About Surrogate Markers and Disease Outcomes? (Slides with Transcript)
UNDERSTANDING SCIENCE: SURROGATE MARKERS | Evidence Based Training
PPT - Surrogate Markers and its role in the Drug Development Process PowerPoint Presentation - ID:533855
Surrogate markers are not 'one-size-fits-all' | Cleveland Clinic Journal of Medicine
Copeptin, a surrogate marker for vasopressin, is associated with chronic kidney disease progression in patients with diabetes mellitus (ZODIAC-33) - Media Centre | EASD
Evaluation of a surrogate marker: validity and efficiency - Qu - 2013 - Statistics in Medicine - Wiley Online Library
Surrogate Endpoints | Evidera
What Do We Know About Surrogate Markers and Disease Outcomes? (Slides with Transcript)
JCM | Free Full-Text | Corneal Hysteresis, Intraocular Pressure, and Progression of Glaucoma: Time for a “Hyst-Oric” Change in Clinical Practice?
Pulsatile energy consumption as a surrogate marker for vascular afterload improves with time post transcatheter aortic valve replacement in patients with aortic stenosis | Hypertension Research
Noninvasive Testing and Surrogate Markers in Invasive Fungal Diseases - Incacare
Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies - ScienceDirect
Reasons for failure of surrogate markers in predicting endpoints.... | Download Scientific Diagram
